United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - ibandronic sodium monohydrate - tablet - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - ibandronic sodium monohydrate - tablet - 50mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ibandronic acid - tablet - 150 mg

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - ibandronic acid - film-coated tablet - ibandronic acid 150 mg - drugs for treatment of bone diseases

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - sodium ibandronate monohydrate 168,79 mg - eq. ibandronic acid 150 mg - film-coated tablet - 150 mg - ibandronate sodium monohydrate - ibandronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - ibandronate sodium monohydrate - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - ibandronic acid - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - hypercalcemia; breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases - bondronat is indicated for:prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases;treatment of tumour-induced hypercalcaemia with or without metastases.

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1). a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ibandronate sodium monohydrate - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid